OOIR: Observatory of International Research

Papers

(The TQCC of Addiction Science & Clinical Practice is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Smartphone apps for managing alcohol consumption: a literature review	64
Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review	47
Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model	33
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review	29
Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Netwo	28
The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis	27
PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment	27
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis	26
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled tr	26
Multiple clinical risks for cannabis users during the COVID-19 pandemic	26
Adapting inpatient addiction medicine consult services during the COVID-19 pandemic	22
Racial/ethnic equity in substance use treatment research: the way forward	22
Choosing internet-based treatment for problematic alcohol use—why, when and how? Users’ experiences of treatment online	19
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review	18
Substance use disorder bridge clinics: models, evidence, and future directions	17
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 “optimizing retention, duration and discontinuation strategie	17
The impact of project ECHO on physician preparedness to treat opioid use disorder: a systematic review	17
Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities	16
Reimagining brief interventions for alcohol: towards a paradigm fit for the twenty first century?	16
Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis	16
Integrating traditional practices and social network visualization to prevent substance use: study protocol for a randomized controlled trial among urban Native American emerging adults	15
‘Treat my whole person, not just my condition’: qualitative explorations of hepatitis C care delivery preferences among people who inject drugs	15
Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community	15
External validation of an opioid misuse machine learning classifier in hospitalized adult patients	14
“It’s way more than just writing a prescription”: A qualitative study of preferences for integrated versus non-integrated treatment models among individuals with opioid use disorder	14

What do clinicians want? Understanding frontline addiction treatment clinicians’ preferences and priorities to improve the design of measurement-based care technology	14
Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems	14
What is the prevalence of current alcohol dependence and how is it measured for Indigenous people in Australia, New Zealand, Canada and the United States of America? A systematic review	14
Study protocol for a group-based motivational interviewing brief intervention to reduce substance use and sexual risk behavior among young adults experiencing homelessness	13
Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients	13
Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized contro	12
Should the CIWA-Ar be the standard monitoring strategy for alcohol withdrawal syndrome in the intensive care unit?	12
Clinicians’ perspectives and perceived barriers to caring for patients with alcohol use disorder and cirrhosis	12
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder	12
Clinical leaders and providers’ perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs’ facilities	11
“At least someone thinks I’m doing well”: a real-world evaluation of the quit-smoking app StopCoach for lower socio-economic status smokers	11
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative	11
Prevalence of marijuana use in pregnant women with concurrent opioid use disorder or alcohol use in pregnancy	11
Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial	11
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes	11
Understanding the client characteristics of Aboriginal residential alcohol and other drug rehabilitation services in New South Wales, Australia	10
Assessing the readiness of digital data infrastructure for opioid use disorder research	10
Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care	10
Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdown	10
What can primary care services do to help First Nations people with unhealthy alcohol use? A systematic review: Australia, New Zealand, USA and Canada	10
Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study	9
Integrating a brief alcohol intervention with tobacco addiction treatment in primary care: qualitative study of health care practitioner perceptions	9
One size doesn’t fit all: a thematic analysis of interviews with people who have stopped participating in Narcotics Anonymous in Norway	9
Perceived family cohesion, social support, and quality of life in patients undergoing treatment for substance use disorders compared with patients with mental and physical disorders	9
Factors associated with patient-reported experiences and outcomes of substance use disorder treatment in Cape Town, South Africa	9
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates	8
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule	8
Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders	8
The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting	8
Housing, opportunities, motivation and engagement (HOME) for homeless youth at-risk for opioid use disorder: study protocol for a randomized controlled trial	8
Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial	8
Merging statewide data in a public/university collaboration to address opioid use disorder and overdose	7
Problem opioid use and HIV primary care engagement among hospitalized people who use drugs and/or alcohol	7
Patient outcomes and experience of a task-shared screening and brief intervention service for problem substance use in South African emergency centres: a mixed methods study	7
Information technology and addiction science: promises and challenges	7
Addressing complex pharmacy consultations: methods used to develop a person-centred intervention to highlight alcohol within pharmacist reviews of medications	7
Care-engaged individuals with polysubstance use in Northeastern US are undertreated for methamphetamine use disorder: a retrospective cohort study	7
Expanding access to medications for opioid use disorder through locally-initiated implementation	6
Feasibility and acceptability of electronic administration of patient reported outcomes using mHealth platform in emergency department patients with non-medical opioid use	6
Identifying unique barriers to implementing rural emergency department-based peer services for opioid use disorder through qualitative comparison with urban sites	6
Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego County	6
Improving Treatment Together: a protocol for a multi-phase, community-based participatory, and co-design project to improve youth opioid treatment service experiences in British Columbia	6
Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-fe	6
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone	6
How do state Medicaid programs determine what substance use disorder treatment medications need prior authorization? An overview for clinicians	6
Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol	6
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis	6